A bivalent Neisseria meningitidis recombinant lipidated factor H binding protein vaccine in young adults: Results of a randomised, controlled, dose-escalation phase 1 trial

Peter Richmond; M.D. Nissen; H.S. Marshall; S.B. Lambert; D. Roberton; W.C. Gruber; T.R. Jones; A. Arora

doi:10.1016/j.vaccine.2012.07.065

A bivalent Neisseria meningitidis recombinant lipidated factor H binding protein vaccine in young adults: Results of a randomised, controlled, dose-escalation phase 1 trial

Peter Richmond, M.D. Nissen, H.S. Marshall, S.B. Lambert, D. Roberton, W.C. Gruber, T.R. Jones, A. Arora

Research output: Contribution to journal › Article › peer-review

Original language	English
Pages (from-to)	6163-6174
Journal	Vaccine
Volume	30
Issue number	43
DOIs	https://doi.org/10.1016/j.vaccine.2012.07.065
Publication status	Published - 2012

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1016/j.vaccine.2012.07.065

Cite this

Richmond, P., Nissen, M. D., Marshall, H. S., Lambert, S. B., Roberton, D., Gruber, W. C., Jones, T. R., & Arora, A. (2012). A bivalent Neisseria meningitidis recombinant lipidated factor H binding protein vaccine in young adults: Results of a randomised, controlled, dose-escalation phase 1 trial. Vaccine, 30(43), 6163-6174. https://doi.org/10.1016/j.vaccine.2012.07.065

@article{3809e8af96d643179c8d889f84a2e575,

title = "A bivalent Neisseria meningitidis recombinant lipidated factor H binding protein vaccine in young adults: Results of a randomised, controlled, dose-escalation phase 1 trial",

author = "Peter Richmond and M.D. Nissen and H.S. Marshall and S.B. Lambert and D. Roberton and W.C. Gruber and T.R. Jones and A. Arora",

year = "2012",

doi = "10.1016/j.vaccine.2012.07.065",

language = "English",

volume = "30",

pages = "6163--6174",

journal = "Vaccine",

issn = "0264-410X",

publisher = "Elsevier",

number = "43",

}

TY - JOUR

T1 - A bivalent Neisseria meningitidis recombinant lipidated factor H binding protein vaccine in young adults: Results of a randomised, controlled, dose-escalation phase 1 trial

AU - Richmond, Peter

AU - Nissen, M.D.

AU - Marshall, H.S.

AU - Lambert, S.B.

AU - Roberton, D.

AU - Gruber, W.C.

AU - Jones, T.R.

AU - Arora, A.

PY - 2012

Y1 - 2012

U2 - 10.1016/j.vaccine.2012.07.065

DO - 10.1016/j.vaccine.2012.07.065

M3 - Article

C2 - 22871351

SN - 0264-410X

VL - 30

SP - 6163

EP - 6174

JO - Vaccine

JF - Vaccine

IS - 43

ER -